News

Elsevier, a global information and analytics company, today launches PharmaPendium AI, a generative AI assistant for ...
Elsevier is introducing Embase AI, a GenAI-powered version of Embase, the leading biomedical literature database, to transform literature searches and other tasks carried out by multiple teams, ...
Scientific publishing giant Elsevier put out a total of six publications between 2000 and 2005 that were sponsored by unnamed pharmaceutical companies and looked like peer reviewed medical journals, ...
London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, ...
Elsevier this week announced its acquisition of Pittsburgh-based Via Oncology, a former subsidiary of UPMC that develops clinical decision support tools for cancer care management. Via Oncology's ...
It started earlier this month, when Elsevier sent open access forum Academia.edu 2,800 takedown notices for articles it owns the copyright to within a couple of weeks. Academia.edu is a ...
In a new study published in Cell00917-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867425009171 ...
Elsevier saw 2% underlying revenue growth in 2018, according to the latest annual financial results filed by parent company RELX, to a total of £2,538m. At constant currency, the rise was 4%. Adjusted ...
Publishing company Elsevier has backpedalled on its support of the Research Works Act (RWA), a bill that proposes to stop federal agencies from requiring that their grantees deposit federally funded ...
University of Western Australia provides funding as a founding partner of The Conversation AU. The academic publisher Elsevier last week filed a complaint against two web sites who it accuses of ...